Evidence map›Paper›PMID 42639652›Full record

ArticleThoracic cancer2026

Decision-Support Framework for Nutritional Risk in Small Cell Lung Cancer: A Time-Series Model Using Imputation Strategies for Incomplete Clinical Data.

Ruili Pan, Yifan Zhao, Mengzhao Wang, Weida Liu, Shuo Ji, Ya Liu, Yuchen Zhang, Chenxi Ma, Minjiang Chen, Yan Xu

Abstract read
In one paragraph

Article in Thoracic cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruili PanDepartment of Nursing, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-1937-2045
Yifan ZhaoClinical Research Validation Platform, National Facility for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mengzhao WangDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-9226-5393
Weida LiuPeking Union Medical College Hospital, State Key Laboratory for Complex Severe and Rare Diseases, Institute of Clinical Medicine, Chinese Academy of Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0002-2002-5833
Shuo JiClinical Research Validation Platform, National Facility for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ya LiuDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuchen ZhangClinical Research Validation Platform, National Facility for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chenxi MaClinical Research Validation Platform, National Facility for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0001-6256-7027
Minjiang ChenDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-4040-6115
Yan XuDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-2832-2664

Funding

CAMS Innovation Fund for Medical Sciences (CIFMS) 2024-I2M-C&T-B-006
6 · The paper itself

Abstract

In patients with small cell lung cancer (SCLC), nutritional status is a key determinant of disease progression, treatment tolerance, and prognosis. The prognostic nutritional index (PNI), reflecting both immune and nutritional conditions, is widely used to evaluate prognostic risk, but its longitudinal monitoring is often limited by incomplete clinical data in real-world settings. This study aimed to propose a decision-support framework for predicting future nutritional status and improving risk screening in SCLC patients with missing data. Using PNI values and related variables from the first four follow-up time points to predict the PNI at the fifth time point (PNI5) and evaluated the impact of different missing data imputation strategies on predictive performance. Missing PNI values were imputed using mean imputation, multiple imputation (MI), Kalman filtering, k-nearest neighbors (KNN), and XGBoost imputation. Predictive models were developed with two machine learning algorithms: random forest (RF) and XGBoost. The RF model demonstrated better overall performance, and MI combined with RF achieved the best predictive accuracy (MAE: 2.952; RMSE: 3.727). Predicted PNI values were further translated into risk categories using a predefined threshold (PNI = 45), with overall accuracy of 93.33%, PPV 95.24%, and NPV 92.59%. Importantly, the model enabled risk assessment in patients with incomplete laboratory data, covering previously unassessable cases and reducing monitoring gaps. This study highlights the importance of appropriate imputation strategies in and provides a practical tool for continuous nutritional risk assessment and early identification of high-risk patients in SCLC.

Indexed as

Lung NeoplasmsNutritional StatusSmall Cell Lung CarcinomaAgedFemaleHumansMaleMiddle AgedNutrition AssessmentPrediction AlgorithmsPredictive Learning ModelsPrognosisRandom Forestmachine learning modelsmissing data imputationpredictive modelingprognostic nutritional index (PNI)small cell lung cancer (SCLC)

Identifiers

PMID42639652
PMCPMC13504445

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.